Dimed S.A. Distribuidora de Medicamentos

B3:PNVL3.SA

10.02 (BRL) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 4,461.0173,990.4753,225.4082,819.112,724.682,432.2462,258.2464,257.4641,986.0261,887.0763,480.841,5241,345.6321,190.6591,074.63933.239832.805733.526
Cost of Revenue 3,282.8942,747.9372,236.8091,995.4151,915.7671,716.2521,721.7361,608.4471,534.4541,467.671,358.3991,181.2781,055.199934.349843.226773.057679.11594.598
Gross Profit 1,178.1231,242.538988.599823.695808.913715.994536.512,649.017451.572419.4062,122.441342.722290.433256.31231.404160.182153.695138.928
Gross Profit Ratio 0.2640.3110.3070.2920.2970.2940.2380.6220.2270.2220.610.2250.2160.2150.2150.1720.1850.189
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 11.75110.0818.7765.2438.5819.9374.1593.41851.74147.4963.49935.43129.54424.29525.31120.82919.41616.874
Selling & Marketing Expenses 221.042210.06170.888143.763152.4131.303131.108160.499403.658377.619107.213277.191234.866202.371162.611133.931111.59103.277
SG&A 1,035.159220.141179.664149.006160.981141.24135.267163.917455.399425.115110.712312.622264.41226.666187.922154.76131.006120.151
Other Expenses 0.379884.672705.981580.518520.731.0640.1270.1260.084-86.9890.033-49.223-38.385-23.972-1.574-2.87-0.743-1.629
Operating Expenses 1,035.1591,104.813885.645729.524681.711605.388441.883436.572361.013338.126310.214263.399226.025202.694186.348151.89130.263118.522
Operating Income 142.964149.011121.61877.858117.002111.616104.275104.89262.00161.5171.29979.32351.56953.61648.07810.16917.56918.657
Operating Income Ratio 0.0320.0370.0380.0280.0430.0460.0460.0250.0310.0330.020.0520.0380.0450.0450.0110.0210.025
Total Other Income Expenses Net -51.38-70.581-38.379-24.554-36.161-18.995-30.33-32.1872.47-16.865-6.128-14.7290-10.3860000
Income Before Tax 91.58478.4383.23953.30480.84192.62173.94572.71262.00161.5171.29964.59451.56943.2348.07810.16917.56918.657
Income Before Tax Ratio 0.0210.020.0260.0190.030.0380.0330.0170.0310.0330.020.0420.0380.0360.0450.0110.0210.025
Income Tax Expense -1.321-7.9153.813-2.8474.08617.63914.14719.65316.73312.15115.15417.48914.14712.45711.3663.5215.4565.59
Net Income 92.90586.34579.42656.15176.75574.98259.79853.05945.26849.35956.14547.10537.42230.77329.6979.68914.17314.402
Net Income Ratio 0.0210.0220.0250.020.0280.0310.0260.0120.0230.0260.0160.0310.0280.0260.0280.010.0170.02
EPS 0.620.580.530.370.570.550.430.380.330.360.410.340.270.220.210.070.10.1
EPS Diluted 0.620.580.530.370.570.550.430.380.330.360.410.340.270.220.210.070.10.1
EBITDA 343.118333.579279.392195.635212.339131.273110.947112.93498.60295.53684.86588.07671.51866.2651.90414.28223.43220.406
EBITDA Ratio 0.0770.0840.0870.0690.0780.0540.0490.0270.050.0510.0240.0580.0530.0560.0480.0150.0280.028